title: Rectal cancer: An evidence-based update for primary care providers.
abstract: Rectal adenocarcinoma is an important cause of cancer-related deaths worldwide, and key anatomic differences between the rectum and the colon have significant implications for management of rectal cancer. Many advances have been made in the diagnosis and management of rectal cancer. These include clinical staging with imaging studies such as endorectal ultrasound and pelvic magnetic resonance imaging, operative approaches such as transanal endoscopic microsurgery and laparoscopic and robotic assisted proctectomy, as well as refined neoadjuvant and adjuvant therapies. For stage II and III rectal cancers, combined chemoradiotherapy offers the lowest rates of local and distant relapse, and is delivered neoadjuvantly to improve tolerability and optimize surgical outcomes, particularly when sphincter-sparing surgery is an endpoint. The goal in rectal cancer treatment is to optimize disease-free and overall survival while minimizing the risk of local recurrence and toxicity from both radiation and systemic therapy. Optimal patient outcomes depend on multidisciplinary involvement for tailored therapy. The successful management of rectal cancer requires a multidisciplinary approach, with the involvement of enterostomal nurses, gastroenterologists, medical and radiation oncologists, radiologists, pathologists and surgeons. The identification of patients who are candidates for combined modality treatment is particularly useful to optimize outcomes. This article provides an overview of the diagnosis, staging and multimodal therapy of patients with rectal cancer for primary care providers.
authors.affiliation: Wolfgang B Gaertner, Mary R Kwaan, Robert D Madoff, Genevieve B Melton, Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, United States.
authors.forename: Wolfgang B
authors.initials: WB
authors.lastname: Gaertner
authors.affiliation: Wolfgang B Gaertner, Mary R Kwaan, Robert D Madoff, Genevieve B Melton, Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, United States.
authors.forename: Mary R
authors.initials: MR
authors.lastname: Kwaan
authors.affiliation: Wolfgang B Gaertner, Mary R Kwaan, Robert D Madoff, Genevieve B Melton, Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, United States.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Madoff
authors.affiliation: Wolfgang B Gaertner, Mary R Kwaan, Robert D Madoff, Genevieve B Melton, Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, United States.
authors.forename: Genevieve B
authors.initials: GB
authors.lastname: Melton
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D006801:Humans; D018579:Patient Selection; D011237:Predictive Value of Tests; D011320:Primary Health Care; D012004:Rectal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D012307:Risk Factors; D016896:Treatment Outcome
keywords: Diagnosis; Primary care; Rectal cancer; Review; Treatment